Endocannabinoid System: Cannabis, Pregnancy & Cytokines
Cannabis use during pregnancy is linked to suppression of maternal immune signaling proteins called cytokines. This immune modulation may impact pregnancy health and fetal development. Understanding cannabis use during pregnancy is critical for informed…
Endocannabinoid System & Cannabis-Induced Psychosis Research
Cannabis-induced psychosis schizophrenia risk is a critical concern for clinicians. A significant portion of patients with cannabis-induced psychosis later develop schizophrenia spectrum or bipolar disorder. Early identification and structured follow-up…
Endocannabinoid System & Teen Anxiety: Clinical Evidence
Internalising symptoms adolescent cannabis use is linked to increased risk of initiation and escalation among teens. This clinical evidence highlights the importance of screening for anxiety and depression in adolescents. Understanding these risks can…
Endocannabinoid System & Trauma Sleep Research Insights
Pre-trauma insomnia and substance use are linked in trauma survivors, increasing risk for problematic alcohol and cannabis use. Early posttraumatic stress symptoms partially mediate this relationship. Addressing sleep disturbances may reduce substance…
Trauma-Focused Treatment and Cannabis Use in PTSD Care
Trauma-focused treatment PTSD cannabis use remains effective even with co-occurring substance use disorders. Cannabis use does not reduce the benefits of trauma-focused psychotherapy. This insight supports maintaining evidence-based PTSD care protocols.
Cannabinoids for Chronic Pain: Evidence and Clinical Insights
Cannabinoid efficacy chronic pain clinical evidence shows modest but consistent pain reduction in controlled trials. Clinical outcomes vary by product formulation and patient factors. This evidence supports cautious, individualized use in pain management.
Endocannabinoid System & PTSD: Cannabis Meta-Analysis
This meta-analysis examines cannabis use trauma-focused treatment in individuals with PTSD and co-occurring substance use disorders. Findings show trauma-focused therapies remain effective despite cannabis use. Cannabis use trauma-focused treatment does…
VER-01 Cannabis Extract: Phase 3 Trial for Chronic Back Pain
The VER-01 cannabis extract clinical trial evaluated 820 adults with chronic low back pain in a rigorous phase 3 study. Results demonstrated significant pain reduction and a favorable safety profile. This trial adds important clinical evidence for…
Endocannabinoid System: Cannabis for Chronic Pain Review
Cannabis-based products for chronic pain clinical evidence shows modest but measurable reductions in pain severity compared to placebo. The quality of evidence varies by THC-to-CBD ratio, product type, and delivery method. Patients and clinicians should…
Endocannabinoid System Clinical Research: Athlete Mental Health Insights
Endocannabinoid system clinical research retired athletes reveals key insights into mental health challenges faced by retired professional athletes. This research highlights factors influencing depression and anxiety post-retirement. Clinicians should…